ibrutinib,venetoclax,adct-602
abbvie,roche,janssen,ADC Therapeutics
[' ibru', 'cll', 'venetoclax', 'leusm']
a lovely interview with of here today, who discussed combined ibrutinib + venetoclax for first-line treatment of patients with cll &amp; a phase i trial of adct-602 in r/r b-all. #ash22 #hemonc #leusm #cllsm #allsm #immunoonc 
The Video Journal of Hematological Oncology is dedicated to providing up-to-date information & international expertise on #HemOnc #LeuSM
#LymSM #MMsm #MPN #MDS